Latest articles for Hematology
News
Survey: Cancer-related pain, opioid use up since 2018
Almost half of patients with cancer did not use anything to manage related symptoms, according to an ASCO poll.
News
NIH seeks gene-based cures for HIV, sickle cell disease
The agency is collaborating with the Bill & Melinda Gates Foundation for the $200 million, 4-year project.
News from the FDA/CDC
FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patients
The latest approval is based on results from the phase 3 MAGELLAN and MARINER trials, which included more than 20,000 patients.
Conference Coverage
Early post-ACS bleeding may signal cancer
PARIS – Cancer risk is elevated with bleeding, whether or not DAPT is employed
Opinion
How thin should we go?
Dr. Douglas S. Paauw describes the best approach to anticoagulation in patients with atrial fibrillation who are on anticoagulation, then have a...
News
BRCA2 mutations linked to childhood NHL
Survivors of childhood non-Hodgkin may be at significantly increased risk for breast, ovarian, prostate, and other BRCA2-associated cancers.
News
NOACs benefit early stage chronic kidney disease patients
NOACs reduced risk of several adverse events compared with VKAs in a meta-analysis of chronic kidney disease patients.
CE/CME
Click for Credit: Biomarkers for VTE risk; Exercise & concussion recovery; more
Topics include: No 1 tx for fibromyalgia • Mood & behavior in kids • Biomarkers for VTE risk • Exercise & concussion recovery • Survival...
Conference Coverage
Gabapentin falls short in treating sickle cell pain
NEW ORLEANS – Gabapentin plus standard therapy produced results similar to those of placebo plus standard therapy.
News from the FDA/CDC
CDC warns against misuse of opioid-prescribing guideline
Officials at the Centers for Disease Control and Prevention are advising against misapplication of the agency’s guideline on opioid prescribing....